First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
4Surgical facility utilization rates and revenue per case trends (pricing power and efficiency metrics)
5Debt refinancing activity and leverage ratio trajectory (currently 2.2x D/E, target path toward 1.5x)
6Ambulatory surgery center procedures (~75-80% of revenue): outpatient surgeries across orthopedics, ophthalmology, gastroenterology, pain management, and general surgery
value - The stock trades at 0.6x P/S and 7.0x EV/EBITDA, well below healthcare services peers (typically 10-12x EBITDA)…
Rising interest rates increase borrowing costs on the company's $1.4-1.6B debt load (estimated based on 2.24x D/E ratio)…
Watch on earnings: Monthly elective surgery scheduling trends and case volume growth by specialty (leading indicator of demand), Commercial insurance enrollment levels and employer-sponsored coverage rates (drives payor mix quality), Medicare Physician Fee Schedule updates and ASC payment rate changes (annual CMS rulemaking in November).
One Sentence Summary:
Surgery Partners: the story is balanced — same-facility case volume growth rates (organic demand indicator, typically 2-5% quarterly growth).
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.